Fibrinolysis Shutdown in COVID-19-Associated Coagulopathy: A Crosstalk among Immunity, Coagulation, and Specialists in Medicine and Surgery - 21/05/21
Doi : 10.1016/j.jamcollsurg.2021.03.003
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Le texte complet de cet article est disponible en PDF.
Plan
| Disclosure Information: Nothing to disclose. |
|
| Disclosures outside the scope of this work: Dr Walsh receives lecture payments from Alexion Speakers Bureau. Dr Neal receives payment for board membership from Janssen Pharmaceuticals and CSL Behring, and receives research support from Janssen Pharmaceuticals, Haemonetics, Accriva, Diagnostics, Instrument Laboratories, and Noveome Therapeutics. Other authors have nothing to disclose. |
|
| Support: Dr Neal receives research support from NIH and the US Department of Defense. |
© 2021
American College of Surgeons. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 232 - N° 6
P. 1003-1006 - juin 2021 Retour au numéro
Article précédent
- Delayed Intracranial Hemorrhage after Blunt Head Trauma while on Direct Oral Anticoagulant: Systematic Review and Meta-Analysis
- Thaddeus J. Puzio, Patrick B. Murphy, Heather R. Kregel, Ryan C. Ellis, Travis Holder, Michael W. Wandling, Charles E. Wade, Lillian S. Kao, Michelle K. McNutt, John A. Harvin
- Direct Oral Anticoagulant and Head Trauma: Much Ado About Nothing
- Hasan B. Alam
Bienvenue sur EM-consulte, la référence des professionnels de santé.